Anavex Life Sciences Corp (AVXL)

[Steady_T]

There are two separate things being discussed here.

One thing is an evaluation of 2-73 on its merits and ascribing a probability of a successful MAA application. That evaluation includes considering the safety record of the drug, the low bar of the SOC, and the trial data. That probability is determined by whoever is doing the evaluation.

The other thing is the probability of the Anavex MAA being approved based on that 85% overall approval rate for an accepted MAA applications.

Those are very different ways of evaluating the situation.